课题基金 / 基金详情

SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS

SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
男性避孕药的合成与测试
批准号:
2315186
负责人:
LUDWIG BAUER
金额:
$17.0万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-03-01 至 1996-01-31

项目摘要

项目成果

LUDWIG BAUER的其他基金

相似基金

相关文献

中文摘要
翻译
这项提议的长期目标是开发一种安全的非 具有睾丸后作用模式的荷尔蒙口服男性避孕药。 这项建议是基于观察到的安全口服酮康唑 人类杀真菌剂导致精子射精,这是 固定的。给大鼠灌注酮康唑可使它们 不孕不育。基于酮康唑(1)的结构,它是一种N- 通过取代1(H)-咪唑,合成了一系列 类似的C-取代咪唑(2)用于评价。
英文摘要
The long-term objective of this proposal is to develop a safe non- hormonal oral male contraceptive that has post-testicular mode of action. The proposal is based on the observation that ketoconazole, a safe oral human fungicide causes, causes ejaculation of spermatozoa which are immobilized. Administration of ketoconazole to rats renders them infertile. Based on the structure of ketoconazole (1), which is a N- substituted 1 (H)-imidazole, it is proposed to synthesize a series of analogous C-substituted imidazoles (2) for evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
SYNTHESIS AND TESTING OF MALE CONTRACEPTIVE AGENTS
海外基金